| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $48.9M | -40.7% |
| SG&A Expense | $18.9M | -27.9% |
| Operating Income | -$10.5M | +88.2% |
| Pre-tax Income | -$8.1M | +91.2% |
| Income Tax | -$11K | -120.8% |
| Net Income | -$8.1M | +91.2% |
| EPS (Basic) | -$1.80 | -9.1% |
| EPS (Diluted) | -$1.80 | -9.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.5M | -64.2% |
| Short-term Investments | $28.9M | +0.0% |
| Current Assets | $16.8M | -75.4% |
| Total Assets | $35.4M | -63.7% |
| Current Liabilities | $17.3M | -69.7% |
| Long-term Debt | $36.2M | -0.1% |
| Total Liabilities | $31.2M | -72.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.8M | +53.0% |
| Capital Expenditures | $200K | -93.7% |
| Investing Cash Flow | $29.1M | -69.5% |
| Financing Cash Flow | -$9.1M | -3340.0% |
| Free Cash Flow | -$42.0M | +54.4% |
| Stockholders' Equity |
| $4.2M |
| +127.8% |